Your email has been successfully added to our mailing list.

×
0.0322580645161291 0.0322580645161291 0.0322580645161291 0.0322580645161291 0.021505376344086 0.0172043010752688 0.010752688172043 0.010752688172043
Stock impact report

CytoDyn Anticipates Revenue Commencing in August 2019 from Use of PA-14 and/or PRO 140 in Diagnostic Test

CYTODYN INC (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
Company Research Source: GlobeNewswire
CytoDyn Signs Non-binding Agreement for Diagnostic Licenseand Supply Agreement with IncellDX for PA-14 and/or PRO 140 (non-commercial grade) Collaboration represents an immediate revenue opportunity as a diagnostic test forreceptor occupancy and the existence of CCR5 on cancer tissue and in HIV VANCOUVER, Washington, July 01, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications today announced a non-binding agreement with IncellDX, Inc. for a diagnostic license and supply agreement for the PA-14 antibody (the diagnostic designation of the murine version of PRO 140) and PRO 140, which is humanized PA-14.  Assays to determine the existence of CCR5 on cancer tissue and the receptor occupancy level for HIV patients are believed to be integral for the effective introduction of leronlimab for therapeutic benefits in Show less Read more
Impact Snapshot
Event Time:
CYDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CYDY alerts
Opt-in for
CYDY alerts

from News Quantified
Opt-in for
CYDY alerts

from News Quantified